Membrane scission is essential for intracellular trafficking. While BAR domain proteins such as endophilin have been reported in dynamin-independent scission of tubular membrane necks, the cutting mechanism has yet to be deciphered. Here, we combine a theoretical model, in vitro, and in vivo experiments revealing how protein scaffolds may cut tubular membranes. We demonstrate that the protein scaffold bound to the underlying tube creates a frictional barrier for lipid diffusion; tube elongation thus builds local membrane tension until the membrane undergoes scission through lysis. We call this mechanism friction-driven scission (FDS). In cells, motors pull tubes, particularly during endocytosis. Through reconstitution, we show that motors not only can pull out and extend protein-scaffolded tubes but also can cut them by FDS. FDS is generic, operating even in the absence of amphipathic helices in the BAR domain, and could in principle apply to any high-friction protein and membrane assembly.
21 September 2016 in Proceedings of the National Academy of Sciences
Significance: Lipid membranes are dynamic assemblies, changing shape on nano- to micron-sized scales. Some proteins can sculpt membranes by organizing into a molecular scaffold, dictating the membrane’s shape and properties. We combine microscopy, mathematical modeling, and simulations to explore how Bin/Amphiphysin/Rvs proteins assemble to form scaffolds on nanotubes. We show that the way protein locally deforms the membrane affects where it will nucleate before making a scaffold. In this process, the protein’s amphipathic helices—which shallowly insert into the membrane—seem dispensable. Surprisingly, the scaffold forms at low protein density on the nanotube. We simulate a structure of protein scaffolds at molecular resolution, shedding light on how these proteins may sculpt the membrane to facilitate important dynamic events in cells.
While several clathrin-independent endocytic processes have been described so far, their biological relevance often remains elusive, especially in pathophysiological contexts such as cancer. In this study, we find that the tumor marker CD166/ALCAM (Activated Leukocyte Cell Adhesion Molecule) is a clathrin-independent cargo. We show that endophilin-A3—but neither A1 nor A2 isoforms—functionally associates with CD166-containing early endocytic carriers and physically interacts with the cargo. Our data further demonstrates that the three endophilin-A isoforms control the uptake of distinct subsets of cargoes. In addition, we provide strong evidence that the construction of endocytic sites from which CD166 is taken up in an endophilin-A3-dependent manner is driven by extracellular galectin-8. Taken together, our data reveal the existence of a previously uncharacterized clathrin-independent endocytic modality, that modulates the abundance of CD166 at the cell surface, and regulates adhesive and migratory properties of cancer cells.